Zevra Therapeutics, Inc.
Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: ZVRA
Zevra Therapeutics, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker ZVRA. It has reported private securities offerings to the US SEC, most recently $39 million sold in a notice filed in 2021.
Zevra Therapeutics at a glance
What does Zevra Therapeutics do?
Private fundraising reported to the SEC
12 Form D notices; the most recent reported $39.1 million sold (2021).
Frequently asked questions about Zevra Therapeutics
Where is Zevra Therapeutics headquartered?
Zevra Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.
What does Zevra Therapeutics do?
Zevra Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Zevra Therapeutics a public company?
Yes. Zevra Therapeutics, Inc. trades on Nasdaq under the ticker ZVRA.
When was Zevra Therapeutics founded?
The earliest incorporation on record for Zevra Therapeutics, Inc. is in 2014, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.